$M

Macy’s Raises Full Year Outlook After Strong Q2 — Says Inventories ‘Well-Positioned’ Heading Into Second Half Of 2026

Macy's Inc. (M) reported Q2 net sales of $4.9B, up 1.1%, and adjusted EPS of $0.63, beating estimates. Comparable sales rose 1.1%, with Bloomingdale's up 11.3%. The company raised its FY26 outlook, expecting net sales of $21.675B-$21.825B and adjusted EPS of $2.15-$2.35. Inventories increased 2.5% YoY, deemed well-positioned. Stock was down 3% premarket.

Original reporting
Published Sep 12, 2026, 5:26 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 1:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$M
Bullish
high confidence
Mentioned
$M
Relevance
9/10
AlphAI data visualization · based on stocktwits.com
Decision brief

The 30-second read

$MBullishHigh
01

Why it matters

Guidance lift and sales beat indicate stronger consumer demand and effective execution of the Bold New Chapter strategy.

02

Market read

First report of Macy's earnings and guidance raise; material for traders.

03

What to watch

Potential headwinds from higher tariff costs and fuel expenses could pressure margins.

Relevance 9/10Novelty 9/10Timing: premarket Thursday

Background

Macy's Q2 earnings release and FY26 outlook update.

Company-level read

Ticker impact

$MBullishHigh confidence
Context

Macy's reported Q2 results beating estimates and raised FY26 sales and EPS guidance.

Expected impact

Expect short-term price rally despite pre‑market dip.

Evidence & confidence

Guidance lift of $0.20 EPS range and $150M sales increase is material for a large‑cap retailer.

Market effects

Retail sector may see broader optimism as a major department‑store chain raises guidance.

U.S. consumer discretionary stocks could benefit.

Limited to U.S. markets; no direct global ripple.

Counterpoint

The pre‑market sell‑off suggests investors may be pricing in higher inventory risk.

Key entities

  • Tony Spring

    CEO of Macy's who commented on the results.

Related articles

$MHighAI 8/10

Macy’s Posts Strong Financial Results And Raises Guidance

Macy’s (M) reported Q2 earnings of $0.40 per share, beating estimates, with revenue of $4.87B. Comparable sales rose 2.7%, with Bloomingdale’s and Bluemercury seeing significant gains. The company raised full-year guidance to $21.68B-$21.83B in sales and $2.15-$2.35 in EPS. M stock rose 4% premarket.

$MMed

Macy's Inc (M) Looks 38.7% Overvalued on GF Value™

Macy's Inc (M) shares rose 8% to $22.06 on September 11, 2026, after reporting better-than-expected Q2 earnings. The company's dividend yield is 3.35% with a 32% payout ratio and 5% growth over 3 years. However, GF Value™ flags the stock as 38.7% overvalued. Macy's GF Score™ is 73, indicating strengths in profitability and momentum. Insiders have sold $8.8M in shares, while 10 institutional investors hold positions, with mixed activity. The company operates 660 stores and has a market cap of $5.

$MMedAI 8/10

Macy’s (M) Stock Rally Meets Tougher Questions Beyond The Profit Beat

Macy's (M) stock rose 7.7% after Q2 earnings beat expectations, with revenue up slightly to $5.059B and adjusted EPS doubling to $0.64. Comparable sales grew 2.7%, and gross margin reached 41.5%. Management guided full-year comps between 1.0% and 1.5% and gross margin between 38.5% and 38.7%. Analysts debate the sustainability of the rally, with bulls citing growth in beauty and luxury segments, while bears point to traffic fragility and cost pressures.

$MMed

How is Macy’s pulling itself out of its spiral of decline?

Macy’s Inc. reported fiscal Q2 2026 sales of $4.9B, with comparable sales up 2.7%. Bloomingdale’s and Bluemercury led growth, while Reimagine stores outperformed. Adjusted EBITDA rose to $457M. The company raised its 2026 net sales outlook to $21.675B-$21.825B. Experts credit the turnaround strategy for the progress, but note challenges remain.